Comparative investigations by Sans et al [50] and Soriano et al [55] evaluating the differential effectiveness of CAM-immunoneutralising antibodies in murine colitis demonstrated that selective blockade of the VCAM-1 axis was superior to that of the ICAM-1 and MAdCAM-1 axes. This evidence concerns the gene ICAM1 and colitis.